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The Journal of Immunology
Regulatory T Cells in Melanoma Revisited by a Computational
Clustering of FOXP3+ T Cell Subpopulations
Hiroko Fujii,* Julie Josse,† Miki Tanioka,* Yoshiki Miyachi,* Franc¸ois Husson,† and
Masahiro Ono*,‡,x
CD4+ T cells that express the transcription factor FOXP3 (FOXP3+ T cells) are commonly regarded as immunosuppressive regu-
latory T cells (Tregs). FOXP3+ T cells are reported to be increased in tumor-bearing patients or animals and are considered to
suppress antitumor immunity, but the evidence is often contradictory. In addition, accumulating evidence indicates that FOXP3 is
induced by antigenic stimulation and that some non-Treg FOXP3+ T cells, especially memory-phenotype FOXP3low cells, produce
proinflammatory cytokines. Accordingly, the subclassification of FOXP3+ T cells is fundamental for revealing the significance of
FOXP3+ T cells in tumor immunity, but the arbitrariness and complexity of manual gating have complicated the issue. In this article,
we report a computational method to automatically identify and classify FOXP3+ T cells into subsets using clustering algorithms. By
analyzing flow cytometric data of melanoma patients, the proposed method showed that the FOXP3+ subpopulation that had
relatively high FOXP3, CD45RO, and CD25 expressions was increased in melanoma patients, whereas manual gating did not
produce significant results on the FOXP3+ subpopulations. Interestingly, the computationally identified FOXP3+ subpopulation
included not only classical FOXP3high Tregs, but also memory-phenotype FOXP3low cells by manual gating. Furthermore, the
proposed method successfully analyzed an independent data set, showing that the same FOXP3+ subpopulation was increased in
melanoma patients, validating the method. Collectively, the proposed method successfully captured an important feature of mela-
noma without relying on the existing criteria of FOXP3+ T cells, revealing a hidden association between the T cell profile and
melanoma, and providing new insights into FOXP3+ T cells and Tregs. The Journal of Immunology, 2016, 196: 000–000.
R
egulatory T cells (Tregs) are defined as the immuno-
suppressive T cells that suppress the activities of other
T cells through undefined mechanisms, and they are
identified by the transcription factor FOXP3 (1). Although Tregs
are reported to be increased in tumor-bearing patients or animals,
and thereby suppress antitumor immunity (2–4), the evidence is in
fact mixed (5): the increase of FOXP3+ T cells is associated with
poor prognosis in hepatocellular cancer (6), whereas it is related to
good prognosis in colorectal cancer (7). The discrepancy may be
explained by that FOXP3+ T cells include not only regulatory but
also non-Tregs that produce proinflammatory cytokines (8). In
fact, accumulating evidence indicates that FOXP3 is not the de-
finitive marker for the immunosuppressive T cells in humans. The
expression of FOXP3 can be induced in naive T cells by con-
ventional anti-CD3 stimulation (9, 10). In addition, some FOXP3+
T cells, especially memory-phenotype CD45RO+FOXP3low cells,
produce effector cytokines and are not suppressive by an in vitro
assay, suggesting that they are enriched with effector and activated
T cells (9).
Accordingly, the subclassification of FOXP3+ T cells has been a
major issue in human Treg research (8, 9, 11–17). It was proposed
that FOXP3+ T cells could be classified into three functionally
different subpopulations: CD45RO+ (equivalent to CD45RA2)
FOXP3high T cells as classical Tregs with suppressive activity (9,
11), CD45RO2 (or CD45RA+) FOXP3low naive Tregs (9, 12, 13),
and FOXP3lowCD45RO+ non-Tregs (9, 14, 15). This classification
has been used to analyze FOXP3+ T cells in autoimmune diseases
and cancers (8, 9, 16, 17). Unfortunately, however, the definition
of FOXP3+ subpopulations varies between studies, complicating
the problem (18). Meanwhile, recently, Abbas et al. (19) proposed
not to use new terms for Treg subpopulations until a new population
has been extensively demonstrated to be unique, distinct from other
populations and stable, because it is likely to lead to more confusion
and the further jargonizing of immunology. This opinion, however,
ignores the fact that a clustering (classification) approach, whether
manual or automatic gating, is indispensable for summarizing and
analyzing flow cytometric data, and thereby relating immunological
profiles to biological response or disease status (20, 21).
Currently in experimental immunology, any cellular popula-
tions, including FOXP3+ T cells, are almost always identified and
analyzed by manual gating, which is a process of identifying a
cluster of cells by manually drawing regions, or gates, in two-
dimensional graphical representations of the data (22–24). Obvi-
ously, manual gating is subjective and cannot fully use multidi-
mensional flow cytometry data; therefore, the automatic gating
using clustering methods has become an active research area of
bioinformatics over the past several years (23, 25). In fact, a
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preceding study proposed a computational approach to identify a
Treg population, precisely CD4+CD25+DR+FOXP3+ cells (26),
but it did not address the immunological significance of the ap-
proach and that of the identified Treg population.
In this study, we aimed to establish a computational approach
to identify and classify FOXP3+ T cells into subpopulations,
addressing the immunological and clinical significance of the
method, and thereby to revisit the fundamental subclassification
of FOXP3+ T cells. To establish the method, we used a data
set of PBMCs from melanoma patients and healthy controls
(HCs), which previously identified that total FOXP3+ T cells
increased in melanoma patients, and that FOXP3low naive Tregs
and FOXP3low non-Tregs increased as the stage progressed (8).
Furthermore, in this study, we have newly obtained a flow cyto-
metric data set of FOXP3+ T cells from melanoma patients and
HCs (designated as the second data set), to address the efficiency
of the proposed method. Thus, we first show the clinical and
immunological significance of a data-oriented clustering approach
to the subclassification of the FOXP3+ T cells.
Materials and Methods
Patient samples
All PBMC data sets were obtained from patients with malignant mela-
noma who were treated in the Department of Dermatology, Kyoto
University Hospital. The first data set analyzed 23 individuals by
FACSCalibur (BD Biosciences) (8). The second data set analyzed 19
individuals by LSR Fortessa (BD Biosciences). The patients’ charac-
teristics in the second data set are summarized in Table I. We also ob-
tained data from age- and sex-matched HCs (first data set, n = 28; second
data set, n = 15). This study was approved by the Medical Ethics
Committee of Kyoto University and was conducted in accordance with
the principles of the Declaration of Helsinki. All participants provided
written informed consent.
Flow cytometric analysis
PBMCs were isolated with Ficoll–Isopaque (Lymphoprep; Axis-Shield,
Oslo, Norway) gradient centrifugation. All cells were freshly stained
with the following mAbs and analyzed promptly as previously described
(9): FITC-conjugated anti-CD45RO (UCHL1; BD Biosciences); PE-
conjugated anti-CD25 (M-A251; BD Biosciences); PerCP-Cy5.5–conju-
gated anti-CD4 (SK3; BD Biosciences); and biotinylated anti-FOXP3
(236A/E7; eBioscience, San Diego, CA) and allophycocyanin-streptavidin
(BD Biosciences). The second data set (Table I) was obtained by LSR
Fortessa (BD Biosciences), using the following settings for voltage: FSC-A
(319), SSC-A (335), FL1-A (CD45RO, 582), FL2-A (CD25, 478), FL3-A
(CD4, 742), and FL4-A (FOXP3, 676). FlowJo (Tree Star) was used for
manual gating.
Automatic gating of FOXP3+ T cell subpopulations
For data preprocessing, boundary values were removed [i.e., $1000 or
,100 (forward scatter [FSC]), $1000 (side scatter [SSC]), $4 or ,0.3
(fluorescence channels, logged) in the case of analog data; $800 or ,100
(FSC),$1000 (SSC), and$3.5 or,0.1 (fluorescence channels, logged) in
the case of digital data], because they were considered meaningless events
representing cellular debris or large nonlymphocytes, or noise (27). Sub-
sequently, all fluorescence data were log-transformed, and each variable
was normalized by the standardized scaling. In the established classifica-
tion method (the HKK clustering [see the section headed Automatic
classification of the three FOXP3+ T cell subpopulations]), FOXP3+ T cell
subpopulations were identified by the following three steps: first, CD4+
T cells were clustered by a high-dimensional data clustering (HDDC)
function, hddc, of a CRAN package, HDclassif (28) using FSC, SSC,
and CD4 (k = 3). Second, FOXP3+ T cells were clustered by a k-means
clustering of FOXP3 values using kmeans of a CRAN package, Stats (29),
and the cluster containing the centroid with the highest FOXP3 value was
designated as FOXP3+ T cells. The number of clusters (k = 3) was de-
termined by examining the bar plot of the loss variability (30), and also
taking into account the identification of the FOXP3+ cluster that has higher
FOXP3 values than the FOXP32 cloud. Third, finally, FOXP3+ T cell
subpopulations were identified by a k-means clustering, using CD45RO,
CD25, and FOXP3 with k = 3, and subsequently assigned to the Effector-
Treg–like, Naive-Treg–like, and Non-treg–like clusters as follows: 1)
compute the centroid of each cluster and designate the cluster containing
the centroid with the highest value for FOXP3 as effector-Treg–like; and 2)
among the two other clusters, the one with the smallest value for CD45RO
as naive-Treg–like and the last one as non-treg–like. All computational
analyses were done using a laptop with an Intel Core i5-3360 M CPU -
2.80 GHz or a Mac desktop with 3.5 GHz Intel Core i5, OS10.10.4.
Statistical analysis
A Mann–Whitney–Wilcoxon test was used for analyzing two groups,
testing the null hypothesis that the two statuses (i.e., HC or melanoma)
have equal medians. A Kruskal–Wallis test, a nonparametric alternative to
ANOVA, was used for analyzing more than two groups, testing the null
hypothesis that the medians are equal across the groups (HC and disease
stages), followed by pairwise comparisons using a Mann–Whitney–
Wilcoxon test. The p values were adjusted by a Bonferroni procedure for
multiple comparisons in all the analyses.
Results
Manual gating approach to FOXP3+ T cell subpopulations
This section shows how the standard approach, manual gating, iden-
tified and classified FOXP3+ T cells into three subsets: CD45RO+
FOXP3high effector (memory) Treg (effector-Treg population hereaf-
ter), CD45RO2FOXP3low naive Treg (naive-Treg population), and
CD45RO+FOXP3low non-Tregs (non-Treg population) (8, 9) (Fig. 1A).
These subpopulations were identified in a sequential manner using the
FIGURE 1. Manual gating approach to classify the
FOXP3+ T cell subpopulations. The manual gating ap-
proach to identify and classify FOXP3+ T cell subpopu-
lations is depicted. (A) Representative flow cytometric data
showing the three subsets of FOXP3+ T cells in PBMCs:
CD45RO+FOXP3high effector Treg, CD45RO2FOXP3low
naive Treg, and CD45RO+FOXP3low non-Treg. These
subpopulations are classified in a sequential manner using
the following four gates: (B) the lymphocyte gate on the
window displaying FSC and SSC, (C) the CD4+ gate using
CD4 and SSC, (D) the FOXP3+ gate using FOXP3 and
CD45RO, and (E) the FOXP3+ T cell subpopulation gate
using FOXP3 and CD45RO. The level of FOXP3high
and FOXP3low cells was determined so that CD45RO2
FOXP3high cells were ,0.2% of CD4+ T cells.
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following four gates: 1) the lymphocyte gate using FSC and
SSC (Fig. 1B); 2) the CD4+ gate using CD4 and SSC (Fig. 1C);
3) the FOXP3+ gate using FOXP3 and CD45RO to visually
identify a groove of the FOXP3 distribution (Fig. 1D); and 4) the
FOXP3/CD45RO gate to identify the FOXP3+ T cell subpopu-
lations (Fig. 1E). The level of FOXP3 by which FOXP3high
and FOXP3low cells were separated was determined so that
CD45RO2FOXP3high cells were ,0.2% of CD4+ lymphocytes
using HCs (Fig. 1E).
Data-oriented clustering (automatic gating) of FOXP3+ T cell
subpopulations
We aimed to establish an automated clustering method for iden-
tifying FOXP3+ T cells and classifying them into three subpopu-
lations, and thereby to revisit the immunological significance of
the FOXP3+ T cell classification. Importantly, there is no major
controversy regarding the identification of the total FOXP3+ CD4+
T cells, but there are multiple ways to classify FOXP3+ T cells,
which we aimed to address in this study. Thus, we used the fol-
lowing approach to identify the FOXP3+ T cell subpopulations: 1)
to identify FOXP3+CD4+ T cells; and 2) to classify FOXP3+CD4+
T cells into three subpopulations without using the manual gating
strategy. We used the flow cytometric data set in our previous
report, which was obtained by a FACSCalibur (8) (the first data
set), to establish a clustering method.
Automatic gating of FOXP3+ CD4+ T cells. The aim of this step is
to efficiently and robustly identify FOXP3+ CD4+ T cells as de-
scribed earlier. CD4+ cells are distinct from CD42 cells in the
space of FSC, SSC, and CD4 (Fig. 1B, 1C), whereas the distri-
bution of FOXP3 expression is continuous in CD4+ T cells
(Fig. 1D). In fact, a preliminary analysis showed that CD4+
T cells were efficiently identified using a model of HDDC (28),
but not by a common clustering method, k-means. HDDC is based
on Gaussian mixtures with restricted covariance matrices (28) and
can efficiently identify elliptic populations such as CD4+ T cells in
the space of FSC, SSC, and CD4. In contrast, FOXP3+ cells are
not as discrete as CD4+ T cells, and it was not obvious what
method was suitable.
FIGURE 2. Automatic gating of FOXP3+CD4+ T cells. Three clustering methods were compared for identifying FOXP3+CD4+ T cells: CD4+ T cell
selection by HDDC, followed by FOXP3+ T cell selection by k-means (HK clustering); CD4+ T cell selection by HDDC, followed by FOXP3+ T cell
selection by HDDC (HH clustering); and FOXP3+CD4+ T cell selection by one step-HDDC (one-step H clustering). Various random number seeds were
used to resample events from flow cytometric data, and resampling was repeated 100 times for each random number seed, to address the robustness and
efficiency of the three clustering methods. Sensitivities and accuracies were calculated by assuming that the manual gating provides a gold standard. (A–C)
Sensitivities and accuracies of HK and HH: (A) sensitivities and accuracies for identifying CD4+ T cells by HDDC (shared by HK and HH). (B and C)
Sensitivities and accuracies of (B) k-means and (C) HDDC for identifying FOXP3+ T cells from the identified CD4+ T cell cluster (HK and HH, re-
spectively). (D) Sensitivities and accuracies of HDDC for identifying FOXP3+ T cells from all cells (one-step H). (E–G) Representative plots of auto-
matically gated FOXP3+CD4+ T cells by the HK clustering method for (E and F) CD4+ T cells and (G) FOXP3+ T cells. The clustered cells are shown by
black dots.
The Journal of Immunology 3
 at Im
perial College London Library on February 12, 2016
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
Thus, we compared different combinations of the clustering
methods using a resampling approach, addressing the sensitivity
and the accuracy of the methods. In this study, we compared the
following methods: 1) HK clustering: CD4+ T cell selection by
HDDC, followed by FOXP3+ T cell selection by k-means; 2) HH
clustering: CD4+ T cell selection by HDDC, followed by FOXP3+
T cell selection by HDDC; and 3) one-step H clustering: FOXP3+
CD4+ T cell selection by one-step HDDC. Using several random
number seeds, the HK clustering showed the highest sensitivities
and accuracies across different cell numbers compared with the
other methods (Fig. 2).
Automatic classification of the three FOXP3+ T cell subpopulations.
Next, we aimed to establish a method that subclassifies the
FOXP3+CD4+ T cells into three subpopulations without relying on
the manual gating criteria, and thereby to readdress the signi-
ficance of FOXP3+CD4+ T cell subpopulations. We compared
FIGURE 3. Automatic clustering of FOXP3+ CD4+
T cell subpopulations. K-means and HDDC were used
for classifying the computationally clustered FOXP3+
T cells into three subpopulations, and we compared
them for stability using a resampling approach, which
was repeated 100 times. (A–D) Box plots showing (A)
the percentages and the mean fluorescence intensities
(MFI) of (B) CD45RO, (C) CD25, or (D) FOXP3 of
each FOXP3+ T cell subcluster in CD4+ T cells by
either k-means or HDDC in the 100 resampled samples
(i.e., HKK or HKH, respectively). (E and F) Repre-
sentative plots of FOXP3+ T cell subpopulations (E) by
the HKK clustering (automatic) and (F) by manual
gating.
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k-means and HDDC (k = 3; designated as HKK and HKH
clustering methods, respectively) by a resampling approach, to
identify a method that consistently assigns similar cells to each
cluster, using CD45RO, CD25, and FOXP3. The resampling
experiment showed that the HKK clustering had smaller varia-
tions in both the percentage and the mean fluorescence intensi-
ties of CD45RO, CD25, and FOXP3 of each subpopulation than
the HKH clustering (Fig. 3A–D). Thus, the HKK clustering has
been chosen as the method for identifying and classifying the
FOXP3+ T cell subpopulations.
The three clusters identified by the HKK clustering were
partially overlapped with the three subpopulations identified by
manual gating. To make the clusters and the subpopulations
comparable, the cluster with the highest FOXP3 expressions was
designated as effector-Treg–like, and those with low and high
CD45RO expressions were designated as naive-Treg–like and
FIGURE 4. Comparison of the
FOXP3+ T cell clusters/populations
identified by the automatic and manual
gating approaches. (A–D) The auto-
matic (the HKK clustering) and man-
ual gating approaches were compared
by spaghetti plots of the percentage of
the cells that were classified as (A) ef-
fector-Treg–like, (B) non-Treg–like, and
(C) naive-Treg–like, and (D) all FOXP3+
T cells, in all samples including HCs
and melanoma patients. (E–H) Scatter-
plots showing the percentages of each
FOXP3+ T cell cluster/population by
automatic (the HKK clustering) and
manual gating: (E) effector-Treg–like,
(F) non-Treg–like, and (G) naive-Treg–
like, and (H) all FOXP3+ T cells.
Closed and open circles represent mel-
anoma and HC samples, respectively.
All percentages are in CD4+ T cells.
Pearson correlation coefficient (r) was
calculated using all the samples for each
cluster.
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non-Treg–like clusters, respectively (Fig. 3E, 3F). Obviously, the
effector-Treg–like cluster contained not only the cells that were
identified as effector-Treg but also some of the FOXP3low cells
that were identified as non-Treg by manual gating (Fig. 3E, 3F).
The HKK clustering was not computationally expensive: it took
45 s per patient, on average, to perform all three clustering steps
using a conventional laptop.
Statistical comparisons of FOXP3+ T cell subpopulations between
manual and automatic gating. We compared the subpopulations
that were identified by the HKK clustering with those by the
manual gating, to understand the similarities and dissimilarities of
the two approaches. Obviously, the HKK clustering included more
cells in the effector-Treg–like cluster than manual gating, whereas
the latter included more in the non-Treg–like cluster (Fig. 4A–D).
The effector-Treg–like and the non-Treg–like clusters showed
relatively low correlations with their corresponding manually
gated populations (r = 0.6236 and 0.7782, respectively; Fig. 4E,
4F). In contrast, the naive-Treg–like cluster and all FOXP3+
T cells had high correlations with their corresponding manually
gated populations (r = 0.9168 and 0.8947, respectively; Fig. 4G,
4H). All results were statistically significant (p , 0.0001).
Next, the HKK clustering and the manual gating approaches
were compared for association with melanoma. As we previously
reported, the manually gated three subpopulations, effector-Treg,
naive-Treg, and non-Treg, showed a significant difference be-
tween HCs and melanoma patients (p , 0.05) (8). However, as-
suming that the three subpopulations might be related to each
other, when p values were adjusted for multiple comparisons using
a Bonferroni method, all the adjusted p values exceeded 0.05;
thus, the manually identified subpopulations did not show signif-
icant difference using the conservative approach. In contrast,
among the automatically identified clusters, the effector-Treg–like
cluster was significantly increased in melanoma patients compared
with controls (adjusted p = 0.027; Fig. 5). This result suggested
that the effector-Treg–like cluster by the HKK clustering more
efficiently captured the characteristics of melanoma patients.
Application of automatic gating to an independent data set. Lastly,
we attempted to apply the established method to an independent
data set. We have generated a new data set using a different flow
cytometer, LSR Fortessa, analyzing 12 HCs and 19 melanoma
patients (the second data set; Table I). When p values were ad-
justed for the multiple comparisons of the three clusters, only the
effector-Treg–like cluster showed a significant increase in mela-
noma patients compared with HCs by a Mann–Whitney–Wilcoxon
test (adjusted p = 0.0015; Fig. 6), confirming the results of the first
data set. Furthermore, a Kruskal–Wallis test showed that only the
effector-Treg–like cluster was significantly different across HCs
and three disease stages (adjusted p = 0.0014; Fig. 6A). Pair-
wise comparisons of the four different statuses using a Mann–
Whitney–Wilcoxon test showed that the effector-Treg–like
cluster was significantly increased in stages III and IV com-
pared with HCs (adjusted p = 0.0127 and 0.0325, respectively;
Fig. 6B).
Discussion
This study has proposed to use a clustering approach to reveal the
immunological profiles of FOXP3+ T cells without invoking the
concept of the immunosuppressive phenotype of FOXP3+ T cells
(19), and thereby to correlate them with disease phenotype or
biological response. The current dogma of Tregs (i.e., the lineage
perspective) (31) considers that a Treg population can be defined
only when it has been shown to be unique and distinct from other
T cells and stable as a lineage (19). To be compatible with the
lineage perspective, the threshold level of FOXP3 for defining the
effector-Treg subpopulation by manual gating has been deter-
mined based on the result of a suppressive assay (9), the gold
standard for assessing the immunosuppressive function of Tregs
(32, 33). Alarmingly, however, recent studies indicate that the
suppressive activity by the assay is mostly explained by the ab-
sorption of IL-2 in the culture by CD25 (IL-2R a-chain) on the
surface of anergic Treg (34, 35). Because FOXP3 has positive
correlations with CD25 and anergy (36), it is not surprising that
FOXP3highCD45RO+CD25high T cells (i.e., effector-Treg by
manual gating) show a high suppressive activity in the in vitro
assay.
The proposed method revealed that the effector-Treg–like cluster
was significantly increased only in melanoma patients in both of
the data sets, suggesting that this cluster captured an important
immunological feature. These results encourage the computational
clustering approach to reveal the immunological features of
T cells in tumor-bearing patients. In contrast, the computation-
ally identified effector-Treg–like cluster included some memory-
phonotype CD45RO+FOXP3low non-Treg cells by manual gating
(Fig. 3E, 3F, 4A–D) (8, 9). Although the result is difficult to be
interpreted by the lineage perspective, our recently proposed
model of Treg and FOXP3, the feedback control perspective (31),
may be useful for reconciling the results in this study with findings
on Tregs in the literature. Under this new perspective, the increase
of the effector-Treg–like cluster in melanoma patients is inter-
preted as FOXP3 was more frequently induced in tumor-bearing
patients as a consequence of Ag recognition and a negative
feedback mechanism of T cell activation, which also explains the
memory phenotype of the effector-Treg–like cluster. Interestingly,
the second data set analysis showed that the effector-Treg–like
cluster was increased in higher stages of melanoma (stages III
and IV, Fig. 6), which is interpreted by the new model as reactive
FOXP3+ cells accumulated in the immune system as a result of
prolonged chronic stimulation by cancer cells. Although this study
FIGURE 5. Effector-Treg–like cluster in HC and
melanoma patients by the automatic HKK cluster-
ing or manual gating. (A) Box plot showing the
percent effector-Treg–like/CD4 of HC and mela-
noma patients by the automatic HKK clustering.
*Adjusted p , 0.05. (B) Box plot showing the
percent effector-Treg/CD4 of HCs and melanoma
patients by manual gating.
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is not conclusive as to which perspective should be used, certainly
the new perspective allows a more flexible interpretation of clin-
ical and experimental data, because it does not assume stable and
distinct lineages but is more concerned with the dynamics at the
cellular and molecular levels. In fact, a recent study demonstrated
an extensive TCR overlap between FOXP3+ cells and CD25+
FOXP32 cells at the site of inflammation (37), further confirming
that T cells may dynamically change the expression of FOXP3,
especially in disease conditions. Importantly, this view leads to a
question whether the negative feedback mechanism is stronger
than the positive feedback mechanism in melanoma patients, en-
couraging further investigations on the latter in future studies.
The proposed clustering method provided reproducible results
between two independent data sets. Note that the first data set is
in FCS2.0 format, obtained by an analog system, FACSCalibur,
whereas the second data set is in FCS3.0 format, and was obtained
by a digital acquisition system, LSR Fortessa (38). Although a data
normalization method for such different data sets is yet to be
established and is a big issue in flow cytometric data analysis (39),
this study encourages the use of the proposed method or similar
clustering methods for the analysis of complex flow cytometric
data. In our analysis, CD4+ T cell selection was almost identical
between the manual and the automatic approaches (Fig. 2A).
Although the manual gating commonly creates a lymphocyte gate
using FSC and SSC, and subsequently identifies CD4+ T cells
(Fig. 1), our investigation showed that it was more efficient to
identify CD4+ T cells by a one-step HDDC clustering approach
using all FSC, SSC, and CD4. This indicates that CD4+ T cells are
the most distinct when all three dimensions are used. In fact, it is a
common practice in manual gating to use either FSC or SSC to
create a CD4-gate (e.g., Fig. 1C). This result confirms that flow
cytometric data analysis in a higher dimensional space enables
more efficient analysis (23, 25), which is widely accepted but yet
to be further demonstrated by addressing real immunological
problems. In contrast, there is a small discordance in FOXP3+
T cells by the manual gating and by the automatic clustering
(Fig. 2B, left panel), although the overall correlation was high
(r = 0.8947; Fig. 4H). This small discordance may be related
to either or both of the inherent arbitrariness of the manual
gating approach to the FOXP3+ selection and the variations by
k-means. Because FOXP3 is measured by intranuclear staining
and, therefore, its autofluorescence background is high (Fig. 1)
(9, 40), it is experimentally difficult to precisely determine the
boundary between the negative cloud and positive cells without
using FOXP3-deficient T cells from mutant humans (41), which
are practically difficult to be obtained in most laboratories. In ad-
dition, even using such negative controls, it is not obvious where to
set the boundary. This is why the manual gating approach visually
Table I. Patient characteristics in the second data set
Patient No. Age (y)/Sex Type Stage TNM Classification Previous Treatment
1 82/M SSM IA pT1aN0M0 —
2 62/F SSM IB T1bN0M0 —
3 52/M SSM IB T2aN0M0 —
4 59/F SSM IB pT2aN0M0 —
5 63/F ALM IIA pT2bN0M0 —
6 60/M ALM IIC pT4bN0M0 OP, Rec
7 78/F SSM IIC T4bN0M0 —
8 64/M SSM IIIA pT4N2aM0 —
9 53/F SSM IIIA pT2aN1aM0 —
10 54/F SSM IIIB pT1bN1aM0 OP, Rec
11 63/M NM IIIB pT4bN1aM0 —
12 71/F SSM IIIB T1aN1bM0 —
13 33/F ALM IIIB pT3bN2aM0 —
14 78/M ALM IIIC pT4bN3M0 —
15 71/M ALM IV T4bN3M1c OP, CT
16 62/M MU IV pTxN0M1c OP, CT
17 56/F MU IV pTxN0M1c OP, CT
18 39/F SSM IV pTxNxM1c OP, CT, RT
19 59/F ALM IV TxN3M1c OP
ALM, acral lentiginous melanoma; CT, chemotherapy; MU, mucosal melanoma; NM, nodular melanoma; OP, operation; Rec, recurrence; RT,
radiotherapy; SSM, superficial spreading melanoma TNM, Tumor-Node-Metastasis.
FIGURE 6. Application of the automatic gating
approach to an independent data set. The estab-
lished automatic gating method, the HKK cluster-
ing, was applied to an independent data set (the
second data set, see Table I). (A) Box plots showing
%(effector-Treg–like)/CD4 in HCs and melanoma
patients (***adjusted p = 0.0015). (B) Box plots
showing %(effector-Treg–like)/CD4 in HCs and
different disease stages of melanoma patients (I-II,
III, or IV). A Kruskal–Wallis test showed that the
percentages were significantly different across dif-
ferent statuses (adjusted p = 0.0014). Pairwise com-
parisons were done by a Mann–Whitney–Wilcoxon
test, showing significant differences (*adjusted
p , 0.05).
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identifies a groove between the negative cloud and positive cells
and sets it as a boundary for FOXP3+ cells (Fig. 1D). In contrast,
k-means is a method to determine clusters by minimizing the
within-cluster sum of squares (42), and thus can be affected by the
distribution of cells and also by outliers, which can introduce var-
iations. The small discordance of the boundary for FOXP3+ cells
may have contributed to those of the non-Treg–like and naive-Treg–
like clusters as well, because both clusters faced the boundary of
FOXP3+ and FOXP32 cells, whereas it presumably did not directly
affect the effector-Treg–like cluster (Fig. 3E). However, considering
that the proposed automatic gating identified a significant increase
of only the FOXP3+ T cell subpopulation in melanoma patients, and
that the manual gating did not produce any significant results on the
analyzed subpopulations including non-Tregs and naive-Tregs, the
immunological feature of melanoma patients most probably is in
the cells with higher FOXP3 expressions, and the discordance in the
FOXP3 boundary is probably not important in the setting. Yet, it is
hoped that future studies will develop data analytic and modeling
methods to better deal with the problem of where to set the boundary
between negative and positive cells in continuous distributions.
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